• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

源自人肝癌细胞系(KYN-1)的亚系中雄激素受体水平的异质性以及对二氢睾酮的生长反应

Heterogeneity in androgen receptor levels and growth response to dihydrotestosterone in sublines derived from human hepatocellular carcinoma line (KYN-1).

作者信息

Yu L, Kubota H, Imai K, Yamaguchi M, Nagasue N

机构信息

Second Department of Surgery, Shimane Medical University, Izumo, Japan.

出版信息

Liver. 1997 Feb;17(1):35-40. doi: 10.1111/j.1600-0676.1997.tb00776.x.

DOI:10.1111/j.1600-0676.1997.tb00776.x
PMID:9062878
Abstract

Heterogeneity in the growth response to androgen and androgen receptor (AR) status in an AR-positive human hepatocellular carcinoma (HCC) line, KYN-1, was investigated in the present study. Seven sublines were obtained from KYN-1 by the limited dilution method. Four of them had no detectable amounts of AR and did not show any growth response to dihydrotestosterone (DHT) at the concentration up to 1000 nM, while the other three had varying amounts of both cytosolic and nucleosolic AR that were 5- to 7-fold higher than that of the parent cell. In the parent cell, the addition of DHT caused a modest but significant increase in the cell number (21%) in a 14-day culture. Such effect was increased by 2- to 7-fold in two AR-positive sublines. In addition, the sensitivity of the response in these two sublines was increased by up to 24-fold. The one remaining AR-positive subline did not show any growth response to DHT, although the behavior of its AR in sucrose gradient ultracentrifugation and Western blotting was the same as that of the other two sublines. These data clearly show that sublines derived from an established human HCC line have a broad heterogeneity in the growth response of HCC to androgen as well as in AR status and could be classified into three groups on the basis of the growth responsiveness to androgen and the AR expression.

摘要

本研究调查了AR阳性人肝癌(HCC)细胞系KYN-1对雄激素的生长反应及雄激素受体(AR)状态的异质性。通过有限稀释法从KYN-1获得了7个子系。其中4个检测不到AR,在高达1000 nM的浓度下对双氢睾酮(DHT)无生长反应,而另外3个细胞溶质和核溶质AR含量不同,比亲代细胞高5至7倍。在亲代细胞中,添加DHT在14天培养中使细胞数量适度但显著增加(21%)。在两个AR阳性子系中,这种效应增加了2至7倍。此外,这两个子系反应的敏感性提高了24倍。剩下的一个AR阳性子系对DHT无生长反应,尽管其AR在蔗糖梯度超速离心和蛋白质免疫印迹中的行为与其他两个子系相同。这些数据清楚地表明,源自已建立的人肝癌细胞系的子系在肝癌对雄激素的生长反应以及AR状态方面具有广泛的异质性,并且可以根据对雄激素的生长反应性和AR表达分为三组。

相似文献

1
Heterogeneity in androgen receptor levels and growth response to dihydrotestosterone in sublines derived from human hepatocellular carcinoma line (KYN-1).源自人肝癌细胞系(KYN-1)的亚系中雄激素受体水平的异质性以及对二氢睾酮的生长反应
Liver. 1997 Feb;17(1):35-40. doi: 10.1111/j.1600-0676.1997.tb00776.x.
2
Effect of androgens and their manipulation on cell growth and androgen receptor (AR) levels in AR-positive and -negative human hepatocellular carcinomas.雄激素及其调控对AR阳性和阴性人肝细胞癌中细胞生长及雄激素受体(AR)水平的影响
J Hepatol. 1995 Mar;22(3):295-302. doi: 10.1016/0168-8278(95)80282-7.
3
Effects of castration and androgen replacement on tumour growth of human hepatocellular carcinoma in nude mice.去势及雄激素替代对裸鼠人肝细胞癌肿瘤生长的影响。
J Hepatol. 1996 Sep;25(3):362-9. doi: 10.1016/s0168-8278(96)80123-1.
4
Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells.雄激素激活PEG10以促进肝癌细胞的癌变。
Oncogene. 2007 Aug 23;26(39):5741-51. doi: 10.1038/sj.onc.1210362. Epub 2007 Mar 19.
5
Basal and estrogen-stimulated hormone receptor profiles in four R3327 rat prostatic carcinoma sublines in relation to histopathology and androgen sensitivity.
Cancer Res. 1988 Jun 1;48(11):3077-83.
6
Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor.在表达全长人雄激素受体的PC-3前列腺细胞培养物中,雄激素依赖性细胞周期停滞和凋亡性死亡。
Mol Cell Endocrinol. 1997 Jan 3;126(1):59-73. doi: 10.1016/s0303-7207(96)03970-6.
7
Regulation of androgen receptor by androgen and epidermal growth factor in a human prostatic cancer cell line, LNCaP.雄激素和表皮生长因子对人前列腺癌细胞系LNCaP中雄激素受体的调控
Endocrinol Jpn. 1992 Jun;39(3):235-43. doi: 10.1507/endocrj1954.39.235.
8
Inhibition of growth and induction of TGF-beta 1 in human hepatocellular carcinoma with androgen receptor by cyproterone acetate in male nude mice.醋酸环丙孕酮对雄性裸鼠人肝细胞癌雄激素受体生长的抑制及转化生长因子-β1的诱导作用
J Hepatol. 1996 Oct;25(4):554-62. doi: 10.1016/s0168-8278(96)80216-9.
9
Testosterone and 5 alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines.睾酮和5α-二氢睾酮抑制人乳腺癌细胞系的体外生长。
Gynecol Endocrinol. 2002 Apr;16(2):113-20.
10
Androgen binding in nuclear matrix of human genital skin fibroblasts from patients with androgen insensitivity syndrome.雄激素不敏感综合征患者生殖器皮肤成纤维细胞核基质中的雄激素结合
J Clin Endocrinol Metab. 1986 Mar;62(3):542-50. doi: 10.1210/jcem-62-3-542.

引用本文的文献

1
Androgen Receptors Act as a Tumor Suppressor Gene to Suppress Hepatocellular Carcinoma Cells Progression miR-122-5p/RABL6 Signaling.雄激素受体作为一种肿瘤抑制基因抑制肝癌细胞进展:miR-122-5p/RABL6信号通路
Front Oncol. 2021 Oct 20;11:756779. doi: 10.3389/fonc.2021.756779. eCollection 2021.
2
Circular RNA expression is suppressed by androgen receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human hepatocellular carcinoma.环状 RNA 的表达受雄激素受体 (AR) 调节的 RNA 腺苷脱氨酶 (ADAR1) 抑制,在人肝癌中。
Cell Death Dis. 2017 Nov 16;8(11):e3171. doi: 10.1038/cddis.2017.556.
3
Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression.
靶向雄激素受体(AR)→白细胞介素12A信号可增强索拉非尼联合自然杀伤细胞免疫疗法的疗效,从而更好地抑制肝癌进展。
Mol Cancer Ther. 2016 Apr;15(4):731-742. doi: 10.1158/1535-7163.MCT-15-0706. Epub 2016 Mar 3.
4
Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.雄激素受体在肝细胞癌、脂肪肝、肝硬化和肝炎中的作用。
Endocr Relat Cancer. 2014 May 6;21(3):R165-82. doi: 10.1530/ERC-13-0283. Print 2014 Jun.
5
Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma.雄激素受体是治疗肝细胞癌的一个新的潜在治疗靶点。
Gastroenterology. 2008 Sep;135(3):947-55, 955.e1-5. doi: 10.1053/j.gastro.2008.05.046. Epub 2008 May 22.
6
Sex hormone dependency of diethylnitrosamine-induced liver tumors in mice and chemoprevention by leuprorelin.小鼠中二乙基亚硝胺诱导的肝肿瘤的性激素依赖性及亮丙瑞林的化学预防作用
Jpn J Cancer Res. 2001 Mar;92(3):249-56. doi: 10.1111/j.1349-7006.2001.tb01089.x.